6-Benzyl-2-chloro-5,6,7,8-tetrahydro-1,6-naphthyridine

Catalog No. :
ACORIW428
CAS No. :
210539-04-1
Molecular Formula :
C15H15ClN2
Molecular Weight :
258.75

IUPAC Name:6-benzyl-2-chloro-5,6,7,8-tetrahydro-1,6-naphthyridine

6-Benzyl-2-chloro-5,6,7,8-tetrahydro-1,6-naphthyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$50.00Login to see priceIn stockIn stock
5g98%$243.00Login to see priceIn stockIn stock
25g98%$1179.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-Benzyl-2-chloro-5,6,7,8-tetrahydro-1,6-naphthyridine
IUPAC Name6-benzyl-2-chloro-5,6,7,8-tetrahydro-1,6-naphthyridine
MDL No.MFCD09040695
Molecular FormulaC15H15ClN2
Molecular Weight258.75
SMILESClC1=NC2=C(CN(CC3=CC=CC=C3)CC2)C=C1
InChI KeyBPAUBEUYIXYWAV-UHFFFAOYSA-N
Synonym6-benzyl-2-chloro-5,6,7,8-tetrahydro-1,6-naphthyridine | 210539-04-1 | 6-BENZYL-2-CHLORO-7,8-DIHYDRO-5H-1,6-NAPHTHYRIDINE | 1,6-Naphthyridine, 2-chloro-5,6,7,8-tetrahydro-6-(phenylmethyl)- | MFCD09040695 | 6-N-benzyl-2-Chloro-5,6,7,8-tetrahydro-1,6-naphthyridine | SC
CAS No.210539-04-1
PubChem CID16228747

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACORIW428 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACLTOE645 route compound structure diagram
    ACLTOE645601514-58-3 In Stock
  4. Then
  5. ACORIW428 route product structure diagram
    ACORIW428210539-04-1 In Stock
Inquiry

2. ACORIW428 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACORIW428 route product structure diagram
    ACORIW428210539-04-1 In Stock
Inquiry

Comments (0)